FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Diphenoxylate Hydrochloride and Atropine Sulfate (ANI Pharmaceuticals) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Diphenoxylate hydrochloride and atropine sulfate (Diphenoxylate hydrochloride and atropine sulfate)

Snippet

SUPPL AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)